Prognostic factors in Burkitt's lymphoma importance of total tumor burden
- 14 March 1980
- Vol. 45 (6), 1507-1515
- https://doi.org/10.1002/1097-0142(19800315)45:6<1507::aid-cncr2820450634>3.0.co;2-d
Abstract
In 42 patients with African Burkitt's lymphoma, we have studied biochemical and clinical correlations with prognosis. Clinical stage and anti-EA titer were the best predictive factors, but lactic dehydrogenase (LDH) and uric acid (UA) concentrations also correlated with stage and prognosis, whereas lactic acid (LA), which was significantly elevated in Stage D, did not significantly correlate with prognosis or with LDH and UA levels. All of these factors with the possible exception of LA reflect the total body burden of tumor. We conclude that the tumor burden is the single most important prognostic factor in Burkitt's lymphoma, and that this is reflected directly by LDH and UA concentrations, and probably indirectly by anti-EA titer.This publication has 19 references indexed in Scilit:
- Epidemiological evidence for causal relationship between Epstein-Barr virus and Burkitt's lymphoma from Ugandan prospective studyNature, 1978
- Immunosuppression in burkitt's lymphoma. II. Peripheral blood lymphocyte populations related to clinical statusInternational Journal of Cancer, 1976
- Antibodies to Epstein–Barr-Virus Antigens before and after the Development of Burkitt's Lymphoma in a Patient Treated for Hodgkin's DiseaseNew England Journal of Medicine, 1975
- American Burkitt's lymphoma: A clinicopathologic study of 30 casesAmerican Journal Of Medicine, 1975
- Immunosuppression in Burkitt's lymphoma. I. Cutaneous reactivity to recall antigens: Alterations induced by a tumour burden and by BCG administrationInternational Journal of Cancer, 1974
- Surgical Reduction of Tumour Bulk in Management of Abdominal Burkitt's LymphomaBMJ, 1974
- Cell kinetics in Burkitt lymphomaEuropean Journal of Cancer (1965), 1974
- Patterns of Antibodies to Epstein-Barr Virus-Induced Early Antigens in Burkitt's Lymphoma. Comparison of Dying Patients With Long-Term Survivors 2JNCI Journal of the National Cancer Institute, 1973
- Demonstration of two distinct components in the early antigen complex of epstein‐barr virus‐infected cellsInternational Journal of Cancer, 1971
- Immunofluorescence in Cells Derived from Burkitt's LymphomaJournal of Bacteriology, 1966